New Monoterpenoid Indoles with Osteoclast Activities from Gelsemium elegans
Open Access
Abstract
The well-known toxic medicine Gelsemium elegans is widely and historically used to treat bone fracture and skin ulcers by the folk people of China. Two new monoterpenoid indole alkaloids, gelselegandines D and E, together with the known analogue gelegamine A were isolated from G. elegans. Their structures were elucidated by means of spectroscopic techniques and quantum chemical calculations. All isolated compounds were tested for the effects on RANKL-induced osteoclast formation. Interestingly, gelselegandine E and gelegamine A, respectively, showed significant promoting and inhibitory activities on osteoclastogenesis, while gelselegandine D had no activity under the same concentration. This work suggested the different configurations for the carbons near the C-19/20 oxygen rings of the isolated compounds may be the key active groups on osteoclast formation and provided the evidence for the rationality as the traditional treatment for bone-related diseases of G. elegans.Keywords
This publication has 22 references indexed in Scilit:
- Koumine, Humantenine, and Yohimbane Alkaloids from Gelsemium elegansJournal of Natural Products, 2015
- [Mechanism of osteoclast in bone resorption].2014
- Medicinal plants of the genus Gelsemium (Gelsemiaceae, Gentianales)—A review of their phytochemistry, pharmacology, toxicology and traditional useJournal of Ethnopharmacology, 2014
- Global Consensus Statement on Menopausal Hormone TherapyClimacteric, 2013
- Confab – generation of diverse low energy conformersJournal of Cheminformatics, 2011
- Confab - Systematic generation of diverse low-energy conformersJournal of Cheminformatics, 2011
- CurlySMILES: a chemical language to customize and annotate encodings of molecular and nanodevice structuresJournal of Cheminformatics, 2011
- Gelegamines A–E: five new oxindole alkaloids from Gelsemium elegansTetrahedron, 2009
- Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-κB and Akt pathwaysEuropean Journal of Pharmacology, 2008
- Sex Steroids and the Construction and Conservation of the Adult SkeletonEndocrine Reviews, 2002